Sotevtamab, a novel bispecific antibody , is sparking significant excitement within the oncology community, particularly regarding its potential for treating blood cancers. The therapy functions by simultaneously engaging CD3 and the cancer-specific antigen, like CD19, to stimulating an body's re… Read More

Researchers are unveiled the drug, a potential treatment targeting a specific protein involved in tumour development. Preliminary results suggest that Codrituzumab demonstrates notable efficacy in animal studies, potentially providing a new prospect for individuals battling various forms of cance… Read More